Topical therapy in acne

Journal of the European Academy of Dermatology and Venereology

Volumn 11, Issue SUPPL. 1, 1998, Pages

  Gollnick, H ^a   Schramm, M ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Acne treatment; Antibiotics; Azelaic acid; Retinoids

Indexed keywords

ADAPALENE; ANTIANDROGEN; ANTIBIOTIC AGENT; AZELAIC ACID; BENZOYL PEROXIDE; CLINDAMYCIN; ERYTHROMYCIN; GYRASE INHIBITOR; ISOTRETINOIN; RETINOIC ACID; RETINOID; SALICYLIC ACID; SPIRONOLACTONE; SULFUR DERIVATIVE; TAZAROTENE; ZINC;

ACNE VULGARIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; CLINICAL TRIAL; CONFERENCE PAPER; CONTACT ALLERGY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ERYTHEMA; HUMAN; IRRITANT DERMATITIS; PHOTOSENSITIVITY; PRIORITY JOURNAL; TERATOGENICITY; TOPICAL DRUG ADMINISTRATION;

EID: 0032415421     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.1998.tb00901.x     Document Type: Conference Paper

References (33)

1. Gollnick H. The treatment of acne, Drugs Today 1992;8:353-361.
2. Gollnick H, Zouboulis C, Akamatsu H. Pathogenesis and pathogenesis related treatment of acne, J Dermatol 1991;18(9):489-499.
3. Gollnick H, Schramm M. Topical drug treatment in acne. Sebaceous gland, acne and related disorders. Dermatology 1998;196:119-125.
4. Fulton J, Farzad-Bakshandeh A, Bradley S. Studies on the mechanism of action of topical benzoyl peroxide and vitamin A acid in acne vulgaris, J Cutan Pathol 1974;1:191-200.
5. Kligman A, Fulton J, Plewig G. Topical vitamin A acid in acne vulgaris, Arch Dermatol 1969;9:469-476.
6. Nau H. Embryotoxicity and teratogenicity of topical retinoic acid, Skin Pharmacol 1993;6(Suppl):35-44.
7. Buchan P. Evaluation and teratogenic risk of cutaneously administered retinoids, Skin Pharmacol 1993 6(Suppl):45-52.
8. Jick SS, Terris BZ, Jick H. First trimester topical tretinoin and congenital disorders, Lancet 1993;341:1181-1182.
9. Kochhar DM, Christian MS. Tretinoin: a review of the non-clinical developmental toxicology experience, J Am Acad Dermatol 1997;36:S47-S59.
10. Chalker D, Lesher J, Smith J. Efficacy of topical isotretinoin 0.05% gel in acne vulgaris: results of a multicenter, double-blind investigation, J Am Acad Dermatol 1987;17:251-254.
11. Hughes B, Noms J, Cunliffe W. A double-blind evaluation of topical isotretinoin 0.05%, benzoyl peroxide gel 5% and placebo in patients with acne, Clin Exp Dermatol 1992;17:165-168.
12. Shalita A, Weiss JS, Chalker DS, Ellis CN, Greenspan A, Katz HI, Kantor I, Millikan LE, Swinehart T, Swinyer L, Whitmore C, Baker M, Czernielewski J. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial, J Am Acad Dermatol 1996;34(3):482-485.
13. Cunliffe WJ, Caputo R, Dreno B, Förström L, Heenen M, Orfanos CE, Privat Y, Aguilar R, Shalita A, Weiss JS, Chalker DK, Ellis CN, Greenspan AH, Katz I, Kantor I, Millikan LE, Swinehart JM, Swinyer LJ, Whitmore C, Czernielewski J, Verschoore M. Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and US multicenter trials, J Am Acad Dermatol 1997;36:126-134.
14. Shalita AR, Chalker DK, Griffith RF. Double-blind study of AGN 190168, a new retinoid gel, in the topical treatment of acne vulgaris, J Invest Dermatol 1993;100:542A.
15. Nazzarro-Porro M, Passi S, Picardo M. Beneficial effect of 15% azelaic acid on acne vulgaris. Acne and related disorders. Proceedings of an International Symposium, Cardiff, 1988.
16. Gollnick H, Graupe K. Azelaic acid for the treatment of acne: comparative trials, J Dermatol Treat 1989;1:27-30.
17. Akamatsu H, Komura J, Asada Y. Inhibitory effect of azelaic acid on neutrophil function. A possible cause for its efficacy in treating pathogenetically unrelated diseases, Arch Dermatol Res 1991;283:162-166.
18. Tucker S, Flannigan S, Dunbar M. Development of an objective comedogenicity assay, Arch Dermatol 1986;22:660-665.
19. Leeming JP, Holland KT, Cunliffe WJ. The pathological and ecological significance of microorganisms colonising acne vulgaris comedones, J Med Microbiol 1985;20:11-16.
20. Eady EA, Bojar RA, Jones CE, Cove JH, Holland KT, Cunliffe WJ. The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria, Br J Dermatol 1996;34(1):107-113.
21. Eady EA, Farmery MR, Ross JI, Cove JH, Cunliffe WJ. Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients, Br J Dermatol 1994;131(3): 331-336.
22. Bojar R, Eady E, Jones C. Inhibition of erythromycin-resistant propionibacteria on the skin of acne patients by topical erythromycin with and without zinc, Br J Dermatol 194;130:329-336.
23. Chu A, Huber Jr FJ, Plott RT. The comparative safety and efficacy of benzoyl peroxide 5%/erythromycin 3% gel and erythromycin 4%/zinc 1.2% solution in the treatment of acne vulgaris. Sebaceous gland, acne and related disorders. Proceedings of the IVth International Dermatology Symposium, Berlin. Dermatology 1998: in press.
24. Dunlap FE, Maloney JM, Levy S. An investigator-blind, randomized study comparing a 3% erythromycin/5% benzoyl peroxide combination in gel versus 20% azelaic acid cream in the treatment of acne vulgaris. Sebaceous gland, acne and related disorders. Proceedings of the IVth International Dermatology Symposium, Berlin. Dermatology 1998: in press.
25. Lookingbill DP, Chatter DK, Lindholm JS, Katz HI, Kempers SE, Huerter CJ, Swinehart JM, Schelling DJ, Klauda HC. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations, J Am Acad Dermatol 1997;37(4):590-595.
26. Chatter DK, Shalita A, Smith JG, Swann RW. A double-blind study of the effectiveness of a 3% erythromycin and 5% benzoyl peroxide combination in the treatment of acne vulgaris, J Am Acad Dermatol 1983;9(6):933-936.
27. Tucker SB, Tausend R, Cochran R, Flannigan SA. Comparison of topical clindamycin phosphate, benzoyl peroxide, and a combination of the two for the treatment of acne vulgaris, Br J Dermatol 1984;110(4):487-492.
28. Korting HC, Braun-Falco O. Efficacy and tolerability of combined topical treatment of acne vulgaris with tretinoin and erythromycin in general practice, Drugs Exp Clin Res 1989;15(9):447-451.
29. Gollnick H, Vogt K, Hermann J, Blume U, Hahn H, Haustein UF, Orfanos CE. Topical quinolone OPC-7251: a clinical and microbiological study in acne, Eur J Dermatol 1994;4:210-215.
30. Mills O, Kligman A. Is sulphur helpful or harmful in acne vulgaris, Br J Dermatol 1972;86: 620.
31. Lucky A. Topical antiandrogens. Arch Dermatol 1985;121:55-56.
32. Messina M. Oral and topical spironolactone therapies in skin androgenization, Panminerva Med 1990;32:49-55.
33. Chen W, Zouboulis CHC, Orfanos CE. The 5α-reductase system and ist inhibitors, Dermatology 1996;193:177-184.